Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-25002
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeiniger, Sarah-
dc.contributor.authorSchliek, Melanie-
dc.contributor.authorMoser, André-
dc.contributor.authorvon Wyl, Viktor-
dc.contributor.authorHöglinger, Marc-
dc.date.accessioned2022-05-19T11:38:15Z-
dc.date.available2022-05-19T11:38:15Z-
dc.date.issued2022-04-08-
dc.identifier.issn1424-3997de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/25002-
dc.description.abstractWidespread vaccination uptake has been shown to be crucial in controlling the COVID-19 pandemic and its consequences on healthcare infrastructures. Infection numbers, hospitalisation rates and mortality can be mitigated if large parts of the population are being vaccinated. However, one year after the introduction of COVID-19 vaccines, a substantial share of the Swiss population still refrains from being vaccinated.de_CH
dc.language.isoende_CH
dc.publisherEMH Swiss Medical Publishersde_CH
dc.relation.ispartofSwiss Medical Weeklyde_CH
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/de_CH
dc.subjectAdultde_CH
dc.subjectCOVID-19de_CH
dc.subjectSARS-CoV-2de_CH
dc.subjectVaccinationde_CH
dc.subject.ddc614: Public Health und Gesundheitsförderungde_CH
dc.titleDifferences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland : a prospective cohort studyde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
dc.identifier.doi10.4414/smw.2022.w30162de_CH
dc.identifier.doi10.21256/zhaw-25002-
dc.identifier.pmid35429238de_CH
zhaw.funding.euNode_CH
zhaw.issue13de_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume152de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
2022_Heiniger-etal_Differences-Covid19-vaccination-cohort-study.pdf2.93 MBAdobe PDFThumbnail
View/Open
Show simple item record
Heiniger, S., Schliek, M., Moser, A., von Wyl, V., & Höglinger, M. (2022). Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland : a prospective cohort study. Swiss Medical Weekly, 152(13). https://doi.org/10.4414/smw.2022.w30162
Heiniger, S. et al. (2022) ‘Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland : a prospective cohort study’, Swiss Medical Weekly, 152(13). Available at: https://doi.org/10.4414/smw.2022.w30162.
S. Heiniger, M. Schliek, A. Moser, V. von Wyl, and M. Höglinger, “Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland : a prospective cohort study,” Swiss Medical Weekly, vol. 152, no. 13, Apr. 2022, doi: 10.4414/smw.2022.w30162.
HEINIGER, Sarah, Melanie SCHLIEK, André MOSER, Viktor VON WYL und Marc HÖGLINGER, 2022. Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland : a prospective cohort study. Swiss Medical Weekly. 8 April 2022. Bd. 152, Nr. 13. DOI 10.4414/smw.2022.w30162
Heiniger, Sarah, Melanie Schliek, André Moser, Viktor von Wyl, and Marc Höglinger. 2022. “Differences in COVID-19 Vaccination Uptake in the First 12 Months of Vaccine Availability in Switzerland : A Prospective Cohort Study.” Swiss Medical Weekly 152 (13). https://doi.org/10.4414/smw.2022.w30162.
Heiniger, Sarah, et al. “Differences in COVID-19 Vaccination Uptake in the First 12 Months of Vaccine Availability in Switzerland : A Prospective Cohort Study.” Swiss Medical Weekly, vol. 152, no. 13, Apr. 2022, https://doi.org/10.4414/smw.2022.w30162.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.